Keith Baker - 23 Jun 2025 Form 4 Insider Report for KINETA, INC./DE (KANT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
25 Jun 2025, 21:43:52 UTC
Prior SEC filing
16 Apr 2024
Next SEC filing
02 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nanette Agustines, as Attorney-in-Fact

Key filing fact

Keith Baker filed Form 4 for KINETA, INC./DE (KANT) on 25 Jun 2025.

Key facts

  • This page summarizes Keith Baker's Form 4 filing for KINETA, INC./DE (KANT).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 25 Jun 2025, 21:43.

Change

  • Previous filing in this sequence was filed on 16 Apr 2024.
  • Current net transaction value: +$68,612.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001958092 Primary reporting owner

Baker Keith

Relationship
Chief Financial Officer
Address
C/O KINETA, INC., 7683 SE 27TH STREET, SUITE 481, MERCER ISLAND
Signature
/s/ Nanette Agustines, as Attorney-in-Fact
Signature date
25 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KANT transaction

Common Stock

Options Exercise

Transaction value
$81,000
Shares
+225,000
Change %
+1333%
Price
$0.3600
Shares after
241,880
Date
23 Jun 2025
Ownership
Direct
KANT transaction

Common Stock

Tax liability

Transaction value
$12,388
Shares
-47,647
Change %
-20%
Price
$0.2600
Shares after
194,233
Date
23 Jun 2025
Ownership
Direct
KANT transaction

Common Stock

Award

Transaction value
$0
Shares
+53,700
Change %
+28%
Price
$0.000000
Shares after
247,933
Date
25 Jun 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KANT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-225,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
23 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
225,000
Exercise price
$0.3600
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Pursuant to the terms of (i) the Optionholder Treatment Agreement, dated June 16, 2025, by and between Kineta, Inc. (the "Company") and the Reporting Person, and (ii) the Agreement and Plan of Merger, dated as of December 11, 2024, by and among the Company, TuHURA Biosciences, Inc., a Nevada corporation ("TuHURA"), Hura Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of TuHURA, Hura Merger Sub II, a Delaware limited liability company and a wholly owned subsidiary of TuHURA, and Craig Philips, as representative of the stockholders of the Company, and as amended by that certain First Amendment to Agreement and Plan of Merger, dated May 5, 2025, as approved by the Company's stockholders at the Special Meeting of Stockholders held on June 23, 2025, the options granted to the Reporting Person under the 2022 Equity Incentive Plan became fully vested on June 23, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .